95 related articles for article (PubMed ID: 24478481)
1. Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan.
Huang CY; Lai JF; Huang IW; Chen PC; Wang HY; Shiau YR; Cheng YW; Hsieh LY; Chang SC; Lauderdale TL
J Clin Microbiol; 2014 Feb; 52(2):508-16. PubMed ID: 24478481
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil.
Arêas GP; Schuab RB; Neves FP; Barros RR
Mem Inst Oswaldo Cruz; 2014 Nov; 109(7):935-9. PubMed ID: 25410998
[TBL] [Abstract][Full Text] [Related]
3. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.
Green M; Martin JM; Barbadora KA; Beall B; Wald ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):473-6. PubMed ID: 14742197
[TBL] [Abstract][Full Text] [Related]
4. Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.
Meisal R; Andreasson IK; Høiby EA; Aaberge IS; Michaelsen TE; Caugant DA
J Clin Microbiol; 2010 Mar; 48(3):842-51. PubMed ID: 20042624
[TBL] [Abstract][Full Text] [Related]
5. Capsule-Negative emm Types Are an Increasing Cause of Pediatric Group A Streptococcal Infections at a Large Pediatric Hospital in Texas.
Flores AR; Chase McNeil J; Shah B; Van Beneden C; Shelburne SA
J Pediatric Infect Dis Soc; 2019 Jul; 8(3):244-250. PubMed ID: 30085121
[TBL] [Abstract][Full Text] [Related]
6. Clinical, microbiological, and molecular characterization of pediatric invasive infections by
Ramírez de Arellano E; Saavedra-Lozano J; Villalón P; Jové-Blanco A; Grandioso D; Sotelo J; Gamell A; González-López JJ; Cervantes E; Gónzalez MJ; Rello-Saltor V; Esteva C; Sanz-Santaeufemia F; Yagüe G; Manzanares Á; Brañas P; Ruiz de Gopegui E; Carrasco-Colom J; García F; Cercenado E; Mellado I; Del Castillo E; Pérez-Vazquez M; Oteo-Iglesias J; Calvo C;
mSphere; 2024 Mar; 9(3):e0072923. PubMed ID: 38440985
[TBL] [Abstract][Full Text] [Related]
7. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Hsueh PR; Teng LJ; Lee CM; Huang WK; Wu TL; Wan JH; Yang D; Shyr JM; Chuang YC; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Leu HS; Liu CY; Luh KT;
Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
[TBL] [Abstract][Full Text] [Related]
8. emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?
Creti R; Imperi M; Baldassarri L; Pataracchia M; Recchia S; Alfarone G; Orefici G
J Clin Microbiol; 2007 Jul; 45(7):2249-56. PubMed ID: 17494723
[TBL] [Abstract][Full Text] [Related]
9. Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden.
Jasir A; Tanna A; Efstratiou A; Schalén C
J Clin Microbiol; 2001 Feb; 39(2):586-90. PubMed ID: 11158111
[TBL] [Abstract][Full Text] [Related]
10. Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003.
Meisal R; Høiby EA; Aaberge IS; Caugant DA
J Clin Microbiol; 2008 Jun; 46(6):2102-5. PubMed ID: 18417661
[TBL] [Abstract][Full Text] [Related]
11. A novel invasive Streptococcus pyogenes variant sublineage derived through recombinational replacement of the emm12 genomic region.
Unoarumhi Y; Davis ML; Rowe LA; Mathis S; Li Z; Chochua S; Li Y; McGee L; Metcalf BJ; Lee JS; Beall B
Sci Rep; 2023 Dec; 13(1):21510. PubMed ID: 38057343
[TBL] [Abstract][Full Text] [Related]
12. Genetic diversity of cell-invasive erythromycin-resistant and -susceptible group A streptococci determined by analysis of the RD2 region of the prtF1 gene.
Spinaci C; Magi G; Zampaloni C; Vitali LA; Paoletti C; Catania MR; Prenna M; Ferrante L; Ripa S; Varaldo PE; Facinelli B
J Clin Microbiol; 2004 Feb; 42(2):639-44. PubMed ID: 14766830
[TBL] [Abstract][Full Text] [Related]
13. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study.
Jasir A; Tanna A; Noorani A; Mirsalehian A; Efstratiou A; Schalen C
J Clin Microbiol; 2000 Jun; 38(6):2103-7. PubMed ID: 10834960
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.
Baldassarri L; Creti R; Recchia S; Imperi M; Facinelli B; Giovanetti E; Pataracchia M; Alfarone G; Orefici G
J Clin Microbiol; 2006 Aug; 44(8):2721-7. PubMed ID: 16891483
[TBL] [Abstract][Full Text] [Related]
15. Detection of toxigenic M1
Chiang-Ni C; Hsu CY; Yeh YH; Chi CY; Wang S; Tsai PJ; Chiu CH
J Microbiol Immunol Infect; 2024 Apr; 57(2):269-277. PubMed ID: 38278671
[TBL] [Abstract][Full Text] [Related]
16. Genome analysis following a national increase in Scarlet Fever in England 2014.
Chalker V; Jironkin A; Coelho J; Al-Shahib A; Platt S; Kapatai G; Daniel R; Dhami C; Laranjeira M; Chambers T; Guy R; Lamagni T; Harrison T; Chand M; Johnson AP; Underwood A;
BMC Genomics; 2017 Mar; 18(1):224. PubMed ID: 28283023
[TBL] [Abstract][Full Text] [Related]
17. The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study.
Alcolea-Medina A; Snell LB; Alder C; Charalampous T; Williams TGS; ; Tan MKI; Al-Yaakoubi N; Humayun G; Newsholme W; Goldenberg S; Nebbia G; Neil SJD; Batra R; Edgeworth JD
Clin Microbiol Infect; 2023 Jul; 29(7):887-890. PubMed ID: 36925107
[TBL] [Abstract][Full Text] [Related]
18. Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1
Wolters M; Berinson B; Degel-Brossmann N; Hoffmann A; Bluszis R; Aepfelbacher M; Rohde H; Christner M
Infection; 2024 Apr; 52(2):667-671. PubMed ID: 38064158
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological changes in invasive Streptococcus pyogenes infection during the UK alert period: A molecular comparative analysis from a tertiary Spanish hospital in 2023.
Maldonado-Barrueco A; Bloise I; Cendejas-Bueno E; López-Rodrigo F; García-Rodríguez J; Lázaro-Perona F
Enferm Infecc Microbiol Clin (Engl Ed); 2024 Jan; 42(1):34-37. PubMed ID: 38176845
[TBL] [Abstract][Full Text] [Related]
20. Biphasic Outbreak of Invasive Group A Streptococcus Disease in Eldercare Facility, New Zealand.
Worthing KA; Werno A; Pink R; McIntyre L; Carter GP; Williamson DA; Davies MR
Emerg Infect Dis; 2020 May; 26(5):841-848. PubMed ID: 32308193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
